Back to BOL Pharma or All Oil Concentrates

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Medication Details

BOL Pharma
Celixir T10:C200
Carrier Oil
Olive Oil
THC Potential Range (10% Legal Variance)
CBD Potential Range (10% Legal Variance)
Cultivated or Packaged in
Israel Flag of Israel

Stock Availability

We provide stock and pharmacy information for medical cannabis patients only. Cannabis is a controlled substance in the UK and can only be dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed here.

Best Known Status: Discontinued

Main Importer/Distributor (Authoritative Stock)

Dispensing Pharmacies

Product DescriptionPatient Reviews

🇮🇱 About BOL Pharma Ltd

Breath of Life Pharma (BOL Pharma) specializes in medical cannabis, drug development, and CBD APIs. The company operates across the industry's value chain, from growth to finished product, adhering to strict regulatory standards, including Global GAP, GMP, FDA, and EMA. The companys products include dried cannabis flowers, sublingual tablets, and medicated drops with different cannabinoid ratios designed to meet a variety of medical needs and indications.

BOL Pharma is an official supplier to the Hebrew University, the Weizmann Institute, Clalit Health Services (Israels largest HMO), other hospitals and research institutes, and thousands of patients.

Patient Reviews

Coming soon, this feature is currently under active development.

  Prescription cannabis patients struggling with affordability should be allowed to grow their own, as in Canadian Flag Canada and many American Flag American states. Agree? Sign the Government Petition.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)